Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.4599 | 0 | 0.5 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 1.135 | 1 | 0.5 |
Schistosoma mansoni | pyruvate dehydrogenase | 1.135 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 1.135 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 1.135 | 1 | 0.5 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 1.135 | 1 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 1.135 | 1 | 0.5 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 1.135 | 1 | 0.5 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 1.135 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 45 % | Inhibition of DPP4 (unknown origin) using H-Gly-Pro-pNA tosylate as substrate at 0.1 mM after 60 min | ChEMBL. | No reference |
Ki (binding) | = 160 uM | Competitive inhibition of DPP4 (unknown origin) using H-Gly-Pro-pNA tosylate as substrate after 60 min by Michaelis-Menten plot analysis | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.